Eczacıbaşı Pharmaceutical and Industrial Investment Co. Financial Information and Sustainability
...

ECZACIBAŞI
PHARMACEUTICAL AND
INDUSTRIAL INVESTMENT CO.

FINANCIAL INFORMATION AND SUSTAINABILITY

SUMMARIZED FINANCIAL DATA (Thousand TL)

2025

2024

Revenue

9.871.046

11.475.842

Gross Profit

3.292.592

3.897.591

Operating Profit

708.579

916.685

Depreciation and Amortisation

933.724

976.772

EBITDA

1.642.303

1.893.457

Net Income

2.087.820

1.339.742

2025

2024

Total Assets

75.001.701

73.563.710

Total Shareholder's Equity

61.044.204

58.754.916

Total Current Assets

9.673.795

9.932.932

Total Current Liabilities

4.816.000

4.919.498

Liqudity Ratios

2025

2024

Liquidity Ratio

2,01

2,02

Current Ratio

1,56

1,49

The Ratios Related to Financial Structure

2025

2024

Total Liabilities / Total Assets

0,19

0,20

Total Shareholders' Equity / Total Assets

0,81

0,80

Total Shareholders' Equity / Total Liabilities

4,37

3,97

Profitability Ratios

2025

2024

Net Income / Total Shareholders' Equity

0,03

0,02

Net Income / Total Assets

0,03

0,02

Net Income / Revenue

0,21

0,12

Year

Date

Free Issue (%)

Right Issue (%)

Before (TRY)

Now (TRY)

1992

11.11.1992

70

70

150,000

360,000

1994

16.06.1994

115

20

360,000

846,000

1995

13.09.1995

80

-

846,000

1,522,800

1996

25.07.1996

100

-

1,522,800

3,045,600

1999

26.03.1999

300

-

3,045,600

12,182,400

2003

14.05.2003

200

-

12,182,400

36,547,400

2004

13.01.2004

400

-

36,547,200

182,736,000

2008

30.07.2008

200

-

182,736,000

548,208,000

2016

03.11.2016

25

-

137,052,000

685,260,000

Yearly Profit Distribution

2003

28.06.2004

15

13,5

15

-

2004

31.05.2005

7

6,3

7

-

2005

-

-

-

-

-

2006

-

-

-

-

-

2007

26.05.2008

15

12,75

15

-

2008

26.05.2009

11,3

9,605

11,3

2009

25.05.2010

7

5,95

7

2010

24.05.2011

7

5,95

7

2011

19.06.2012

10

8,5

10

-

2012

28.05.2013

10

8,5

10

-

2013

06.05.2014

9,6

8,16

9,6

-

2014

05.05.2015

8

6,8

8

-

2015

10.05.2016

40

34

40

-

2016

08.05.2017

50

42,5

50

-

2017

22.05.2018

20

17

20

-

2018

20.05.2019

30

25,5

30

-

2019

14.04.2020

7,3

6,205

7,3

-

2020

26.04.2021

22

18,7

22

-

2021

24.05.2022

29,2

26,28

29,2

-

2022

25.04.2023

41

36,9

41

-

2023

05.06.2024

118

106.2

118

-

2024

14.05.2025

175,12

148,85

175,12

-

...

ABOUT US

...

CORPORATE MANAGEMENT

...

ANNOUNCEMENTS AND
PRESENTATIONS

...

GENERAL ASSEMBLY